INTRODUCTION
Generalized resistance to thyroid hormone (GRTH) is a genetic disorder characterized by a clinically euthyroid state, an elevated level of free thyroid hormones, and an inappropriately normal or elevated level of thyroid-stimulating hormone (TSH) (Reffetoff, 1982) . The majority of patients with this disorder have been found to have mutations in one allele of the c-erbA~ thyroid hormone receptor gene on chromosome 3 (Usala and Weintraub, 1991; Usala, 1991) . These mutations are located either in the thyroid hormone-binding domain (T~-binding domain) or in the hinge domain of the c-erbA~ receptor (Behr and Loos, 1992) . The variant receptors are supposed to reduce their T3-binding affinity probably by changing their protein structure. However, the relationship between the structure and the functions of the variant receptors have not been studied previously.
We herein report a new point mutation found in a Japanese family, i.e. a cytosine to adenine base change, which causes an amino acid substitution from phenylalanine to leucine in the Ta-binding domain. In addition, we also discuss the secondary structure of the present as well as other mutant thyroid hormone receptors as predicted by the Chou and Fasman method.
CASE REPORT AND METHODS
Clinical studies. The proband was a t4-yr-old girl, who presented with a soft, symmetrically enlarged thyroid gland. She was born at fullterm and gained weight normally in the neonatal period. Her height and weight had never been more than 2 SD below the mean. No history of delayed speech development, hyperactivity, or learning disability was demonstrated. She was within the average range in general performance and intelligence at school. Her physical examination revealed that her height was 146 cm, which was between 1-2 SD below the mean, and she weighed 43 kg. Her resting pulse was 80 beats/min and blood pressure was 110/70 mmHg. No tremor or ocular proptosis was found. Neither her liver nor spleen was enlarged. Therelaxation phase of deep tendon reflexes was not prolonged. Serum total cholesterol was within the normal range. No pituitary tumor was visualized by magnetic resonance imaging of the brain.
Her mother had small diffuse goiter, but she had no stigmata of thyrotoxicosis. She was 40 years old and her height was 155 cm, which was close to the mean. The pulse rate was 70/rain. Neither the liver nor spleen was enlarged. Serum total cholesterol was within the normal range. She had always been in good health. She had no history of hyperactivity. The grandmother of the proband was also pointed out to have earlier had a thyroid disorder, but the details were not known.
DNA preparation and amplification of the c-erbAB gene using the polymerase
Jpn J Human Ge~et chain reaction (PCR) . Blood samples were obtained from individuals, and genomic DNA was isolated from leukocytes by standard procedures (Sambrook et al., 1989) . Exon 5 through 8 of the c-erbA~3 were amplified by PCR (Sakurai et al., 1990) (Exons were designated numerically). The amplification was carried out using Taq polymerase (Promega, Madison, WI) and a supplemented buffer. Routinely 0.5 I.~g portion of genomic DNA was exposed to 24 cycles of amplification, each comprising 1 rain of denaturing at 94~ 1 rain at 55~ for annealing, and 1 rain at 72~ for extension. Primers were synthesized based on the sequences reported by Sakurai et aL (1990) (Table 1 ). Fifty picomoles of the sense and the antisense primers were mixed in each reaction. Direct sequencing of PCR products. The PCR products of each exon were amplified asymmetrically with 50 pmol of the single-sided sense or antisense primers, and then were sequenced in both directions with the opposite primer that was used in the asymmetrical PCR reaction. The asymmetrical PCR products were then purified with the PCR Purification Spin Kit (Qiagen, Chatsworth, CA). Sequencing was performed by the dideoxy method (Tabor and Richardson, 1987) using Sequenase, version 2.0 (United States Biochemical Corp., Cleveland, OH). High specific activity dCTP-5'-[~-82P] (sp. act. 3,000 Ci/mmol) was obtained from New England Nuclear, Wilmington, DE. The samples were run for 1.5-3 h in a 6~ polyacrylamide denaturing gel in 0.5• buffer (Tris/borate/EDTA), pH 8.0, and processed for fluorography.
In vitro expression of normal and mutant e-erbA~. Exon 8 which contained the mutation site was amplified by the PCR of 35 cycles under the conditions described above for the standard PCR. The HindIII restriction site was introduced to the antisense primer; antisense strand, 5'-GGAAGCTTAAAGAGCTAGGCAA-TGGAAT-3'. The PCR products were digested with BgIII (the restriction site of which was present only in exon 8) and HindIII, and purified with Geneclean II. peA101 (American Type Culture Collection, Rockville, MD), containing the entire coding region of the normal c-erbAw gene, was also digested with BgIII and HindIII. The resulting fragment of peA10l lacking Bglll/HindlH fragment was ligated Vol. 39, No. 4, 1994 with the PCR products digested with BglII/HindlIl using T4 DNA ligase (Takara, Kyoto The binding was carried out in a total volume of 0.5 ml containing 20 mM Tris-HC1 (pH 810), 0.3 M KC1, 1 mM MgCI~, and 1 mM dithiothreitol. Nonspecific binding was determined by the addition of a 1,000-fold excess of non-radioactive Ta. Protein bound T 3 was separated from unbound Ta with Centrifree tubes (Amicon, Danvers, MA). Interference by the radioactivity of [~SS]methionine in the filtrate was determined in the absence of [1251]T 3, and the radioactivity was subtracted from all counts. All assays were done in duplicate.
The secondary structure analysis of the thyroid hormone receptor. The secondary structure prediction was performed by the method of Chou and Fasman (Chou and Fasman, 1978) using DNAsis, version 7.00 (Hitachi Software Engineering Co., Yokohama).
RESULTS

Thyroid function tests
The results of the thyroid function tests are shown in Table 2 . The proband demonstrated high levels of thyroid hormones, with an inappropriate secretion of TSH. No circulating antibodies to T 3 and T 4, TSH-binding inhibitory immunoglobulins, or antithyroglobulin antibodies were detected, but the antimicrosomal 
a Thyroxine binding globulin, b Antithyroglobulin antibody, e Antimicrosomal antibody. N.S., not studied.
Jpn J Human Genet antibodies were positive. The TSH response to thyrotropin-releasing hormone (TRH) was inhibited by T 8, but it was still clearly observed even when a supraphysiological dose of T3 was administered (Fig. 1) . Thyroid function tests for her other 3 family members were also performed (Table 2) . Her mother's TSH level was normal in spite of her high thyroid hormone levels, which indicated an inappropriate secretion of TSH. The thyroid hormones and TSH levels in both the patient's father and sister were normal.
Nucleotide sequence of amplified exons of c-erbA~ gene
Asymmetrically amplified exons 5-8 from c-erbA~ gene were sequenced directly by the dideoxy method. These portions of the gene contained the hinge domain and Ta-binding domain. Figure 2 shows a fragment of the sequencing ladder of amplified c-erbA ~ exon 8 from the proband. A C--,A transversion mutation is shown as C and A bands at the same position at nucleotide position 1650. This mutation caused phenylalanine to leucine substitution in codon 450. As expected, sequencing of the antisense strand showed G and T bands at the same position (data not shown). The sequencing of amplified c-erbA~ exon 8 from her parents was also studied. The same point mutation was detected in her mother, while her father had a normal sequence (data not shown). Amplified exons 5-7 from the proband were sequenced, but no other mutations were detected.
T~ binding studies
Mutant and normal receptors were translated in vitro. The sequences of the normal and mutant clone were confirmed by the dideoxy method. When the s~ labeled in vitro translation products were analyzed by SDS-polyacrylamide gel electrophoresis, they displayed the expected 52 and 55 kDa products (data not shown).
The binding affinities for T3 were calculated by the Scatchard analysis. The wildtype receptor T3 binding affinity was 8.3 x 101~ M -1 and the mutant receptor failed to bind T3 (Fig. 3) .
The secondary structure analysis of the thyroid hormone receptor
Figures 4A and B show the predicted secondary structure of the normal and mutant receptors, respectively. The mutant receptor was predicted to have a new turn structure in the 0~ helix structure in the T3-binding domain.
The secondary structure analysis of the previously reported mutant thyroid hormone 2.0- 
receptors
The secondary structure of the previously reported mutant thyroid hormone receptors were predicted by the Chou and Fasman method (Table 3) . Seventeen of the 26 reported mutant receptors (65.4 ~) were predicted to result in some changes of the secondary structure. These changes included 1) ~ helix to [3 sheet, turn, or a Amino acid residue expressed in a one-letter code. b Codon numbering is as described by Weinberger et al. (1986) . e Numbers in parenthesis mean the type of the secondary structure change: 1, a helix to t3 sheet; 2, a helix to turn; 3, a helix to coil; 4, /3 sheet to a helix; 5, t3 sheet to coil; 6, t3 sheet to turn; 7, coil to a helix; 8, coil to/3 sheet; 9, shift of turn; 10, turn to c~ helix; 11, turn to /3 sheet (6, 10, and 11 were not recognized in these mutants). Ka, binding affinity; +, presence of the secondary structure change; -, absence of the secondary structure change; @, deletion; @@, frame shift; N.R., not reported; ~, present case. The secondary structure analysis of the posturated thyroid hormone receptor variants in the region between the two hot spots It has been reported that there are two "hot spot" regions in the Ts-binding domain (Parrilla et aL, 1991) . We studied the secondary structure of the mutant proteins which were postulated to have the same amino acid substitution in the region Table 4 . Predicted changes of the secondary structure of the thyroid hormone receptor variants which were postulated to have the same amino acid substitution in the region between the two hot spots as that in the previously reported mutants.
Mutation
Change of the secondary structure D a346bH + (4) e A347T + (6) F349L D350H + (4) M353T + (5, 9) F358L + (9) D361H + (4, 7, 9) D362H + (4, 7, 9) A366T + (1) L367H L368H A370T + (1) M374T + (3, 9) D377H + (7) R378C R378H P 379 S P379T + (7, 9) G380E + (7, 9) G380V + (7, 9)
The symbols are the same as those in Table 3 .
Jpn J Human Genet between the two hot spots as that in the previously reported variants (Table 4) . Any mutant receptors which could not be caused by a one step mutation were excluded. Twenty-nine of the 42 postulated mutations (69.0~) were predicted to change their secondary structures.
DISCUSSION
The cytosine to adenine base substitution at the nucleotide position 1650 of c-erbA~ gene, which alters phenylalanine to leucine in codon 450, is a new mutation of the c-erbA~ gene. This mutation is thus considered to be responsible for GRTH in this patient. Firstly, the major portion of the c-erbA3 gene (exons 5-8, the hinge domain and the T~-binding domain) was sequenced and it was the only base change found. Secondly, this mutation was found in two affected members of the patient's family (the proband and her mother), but not in an unaffected member (father). Thirdly, this mutation was supposed to alter the secondary structure of the c-erbA~ receptor protein drastically, when predicted by the Chou and Fasman method. Finally, this mutation resulted in the abolishment of the T3-binding activity when the mutant gene was translated in vitro.
The secondary structure of the previously reported mutant thyroid hormone receptors predicted by the Chou and Fasman method revealed that about twothirds of the reported mutant receptors resulted in some changes of the secondary structure. The remaining mutant receptors might alter their tertiary structure.
The reason why mutations have never been found in the region between the two hot spots seems intriguing. There could be three possible causes for this: 1) This region is an area where DNA mutations are only rarely generated. 2) Allelic mutations are generated in this area, but they do not change their protein structures.
3) The structural changes of the receptors are induced, but they do not interfere with their functions as receptors. To gain an insight to this question, we analyzed the secondary structure of the postulated mutant proteins in the region between the two hot spots. Approximately two-thirds of the postulated mutations were predicted to change their secondary structures. These results thus suggest that most of c-erbA~ receptor protein would change their secondary structure if those mutations were generated in this region. It is therefore speculated that the region between the two hot spots is either an area where mutations are hardly generated or an area where the functions as a receptor are hardly disturbed in spite of the presence of structural changes.
Recently, Weiss et al. (1993) reported that the previously reported mutations occurred in CG-rich areas. However, it was also stated that the region between the two hot spots contains CG-rich sequences. They went on to speculate that the failure to detect individuals with mutations in this region can be explained by the inability of the mutant c-erbA~ to exert a "dominant negative effect" through the formation of stable mutant c-erbA~ homodimers, and thus escape clinical recogni-tion. In order to confirm their hypothesis, it is necessary to investigate whether or not the functions of the thyroid hormone receptor variants in this region might be disturbed when the mutations are actually generated by site-directed mutagenesis. Spanjaard et al. (1991) focussed on the region between residues 288-331 of rat cerbA~-I (homologous to the region between 337-380 in human c-erbA~3) and studied the T3 binding affinity of 14 mutant receptors generated by site-directed mutagenesis. Eleven of the 14 mutant receptors showed a decreased binding affinity. Their results suggest that the mutant receptors generated even in this region could have abnormal functions. Consequently, at this moment, we consider that the region between the two hot spots might be an area where mutations are only rarely generated, however, the exact mechanism of this phenomenon thus still remains to be more fully elucidated.
